| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Revenue | $201.1M | +5.2% |
| Cost of Revenue | $112.7M | +9.2% |
| Gross Profit | $88.4M | +0.4% |
| R&D Expense | $6.9M | +7.7% |
| SG&A Expense | $39.0M | -8.4% |
| Operating Income | -$12.5M | +1.6% |
| Pre-tax Income | -$12.3M | -0.4% |
| Income Tax | -$70K | +71.9% |
| Net Income | -$12.2M |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29.7M | +35.3% |
| Accounts Receivable | $25.7M | -4.2% |
| Inventory | $93.3M | -6.4% |
| Current Assets | $155.4M | -1.4% |
| Total Assets | $240.6M | -1.2% |
| Current Liabilities | $29.4M | +27.7% |
| Total Liabilities | $62.7M | +21.2% |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $24.5M | -20.2% |
| Capital Expenditures | $4.8M | +266.4% |
| Investing Cash Flow | -$6.0M | -23.8% |
| Financing Cash Flow | -$10.8M | +54.1% |
| Free Cash Flow | $19.7M | -32.9% |
| -1.9% |
| EPS (Basic) | -$0.94 | -4.4% |
| EPS (Diluted) | -$0.94 | -4.4% |
| Stockholders' Equity |
| $177.9M |
| -7.3% |